Patents by Inventor Benjamin L. Ko

Benjamin L. Ko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230355432
    Abstract: An apparatus includes a body, a needle, a catheter, and an actuator assembly. The needle extends distally from the body. The needle has an inner wall defining a needle lumen. The needle lumen is in fluid communication with a fluid port of the body. The catheter is slidably disposed in the needle lumen. The catheter has a catheter lumen. The first actuator assembly is configured to translate the catheter within and relative to the needle. The apparatus may also include an actuator assembly that is configured to rotate the needle relative to the body. The apparatus may be used to first deliver a leading bleb of fluid to the subretinal space in a patient's eye via the needle. The apparatus may then be used to deliver a therapeutic agent to the subretinal space in the patient's eye via the catheter.
    Type: Application
    Filed: June 29, 2023
    Publication date: November 9, 2023
    Inventors: Michael F. Clem, Benjamin L. Ko, Robert H. Roth, Daniel J. Abbott, Thomas E. Meyer, Paul D. Gordon
  • Patent number: 11759355
    Abstract: A method includes inserting a flexible cannula between a sclera and a choroid of an eye. The needle is advanced from a distal end of the flexible cannula, such that the needle pierces the choroid to access a subretinal space of the eye. The needle is used to deliver a first volume of leading bleb fluid to the subretinal space. The delivery of leading bleb fluid is ceased for a duration of time. After expiration of the duration of time, the needle is used to deliver a second volume of the leading bleb fluid to the subretinal space. The combination of the delivered first and second volumes of the leading bleb fluid causes a substantial portion of the retina to detach from the choroid. A therapeutic agent may then be delivered to the subretinal space in the region where the retina is detached from the choroid.
    Type: Grant
    Filed: February 21, 2020
    Date of Patent: September 19, 2023
    Assignee: Gyroscope Therapeutics Limited
    Inventors: Michael F. Keane, Thomas E. Meyer, Benjamin L. Ko
  • Patent number: 11723798
    Abstract: An apparatus includes a body, a needle, a catheter, and an actuator assembly. The needle extends distally from the body. The needle has an inner wall defining a needle lumen. The needle lumen is in fluid communication with a fluid port of the body. The catheter is slidably disposed in the needle lumen. The catheter has a catheter lumen. The first actuator assembly is configured to translate the catheter within and relative to the needle. The apparatus may also include an actuator assembly that is configured to rotate the needle relative to the body. The apparatus may be used to first deliver a leading bleb of fluid to the subretinal space in a patient's eye via the needle. The apparatus may then be used to deliver a therapeutic agent to the subretinal space in the patient's eye via the catheter.
    Type: Grant
    Filed: September 28, 2020
    Date of Patent: August 15, 2023
    Assignee: Gyroscope Therapeutics Limited
    Inventors: Michael F. Clem, Benjamin L. Ko, Robert H. Roth, Daniel J. Abbott, Thomas E. Meyer, Paul D. Gordon
  • Patent number: 11554042
    Abstract: An apparatus for delivering therapeutic agent to an eye comprises a body, a cannula, a hollow needle, and an actuation assembly. The cannula extends distally from the body and is sized and configured to be insertable between a choroid and a sclera of a patient's eye. The actuation assembly is operable to actuate the needle relative to the cannula to thereby drive a distal portion of the needle along an exit axis that is obliquely oriented relative to the longitudinal axis of the cannula. The cannula may be inserted through a sclerotomy incision to position a distal end of the cannula at a posterior region of the eye, between the choroid and sclera. The needle may be advanced through the choroid to deliver the therapeutic agent adjacent to the potential space between the neurosensory retina and the retinal pigment epithelium layer, adjacent to the area of geographic atrophy.
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: January 17, 2023
    Assignee: Gyroscope Therapeutics Limited
    Inventors: Brendan J. Oberkircher, Daniel W. Price, Michael F. Keane, Saeed Sokhanvar, Daniel J. Yasevac, Michel G. Bruehwiler, Leah R. Soffer, Isaac J. Khan, Benjamin L. Ko, Christopher D. Riemann, Nathan D. Grubbs
  • Publication number: 20220288306
    Abstract: An apparatus includes a body, a cannula, and a needle. The cannula is flexible and extends distally from the body. The needle is slidably disposed in the cannula. The needle includes a sharp distal tip and a curved portion. The needle is configured to translate relative to the cannula between a proximal position and a distal position. The distal tip is configured to be positioned inside the cannula when the needle is in the proximal position. The distal tip is configured to be positioned outside the cannula when the needle is in the distal position. The needle is resiliently biased to extend along a curve through the curved portion.
    Type: Application
    Filed: May 2, 2022
    Publication date: September 15, 2022
    Inventors: Thomas E. Meyer, Benjamin L. Ko, Isaac J. Khan, Daniel W. Price, Brendan J. Oberkircher, Michael F. Keane
  • Patent number: 11338084
    Abstract: An apparatus includes a body, a cannula, and a needle. The cannula is flexible and extends distally from the body. The needle is slidably disposed in the cannula. The needle includes a sharp distal tip and a curved portion. The needle is configured to translate relative to the cannula between a proximal position and a distal position. The distal tip is configured to be positioned inside the cannula when the needle is in the proximal position. The distal tip is configured to be positioned outside the cannula when the needle is in the distal position. The needle is resiliently biased to extend along a curve through the curved portion.
    Type: Grant
    Filed: October 11, 2019
    Date of Patent: May 24, 2022
    Assignee: Gyroscope Therapeutics Limited
    Inventors: Thomas E. Meyer, Benjamin L. Ko, Isaac J. Khan, Daniel W. Price, Brendan J. Oberkircher, Michael F. Keane
  • Publication number: 20210298951
    Abstract: An apparatus for delivering therapeutic agent to an eye comprises a body, a cannula, a hollow needle, and an actuation assembly. The cannula extends distally from the body and is sized and configured to be insertable between a choroid and a sclera of a patient's eye. The actuation assembly is operable to actuate the needle relative to the cannula to thereby drive a distal portion of the needle along an exit axis that is obliquely oriented relative to the longitudinal axis of the cannula. The cannula may be inserted through a sclerotomy incision to position a distal end of the cannula at a posterior region of the eye, between the choroid and sclera. The needle may be advanced through the choroid to deliver the therapeutic agent adjacent to the potential space between the neurosensory retina and the retinal pigment epithelium layer, adjacent to the area of geographic atrophy.
    Type: Application
    Filed: June 14, 2021
    Publication date: September 30, 2021
    Inventors: Brendan J. Oberkircher, Daniel W. Price, Michael F. Keane, Saeed Sokhanvar, Daniel J. Yasevac, Michel G. Bruehwiler, Leah R. Soffer, Isaac J. Khan, Benjamin L. Ko, Christopher D. Riemann, Nathan D. Grubbs
  • Publication number: 20210244566
    Abstract: An apparatus includes a body and a pair of rigid legs extending from the body. The body includes an engagement feature configured to engage a deployment instrument. The legs are parallel with each other. Each leg has a sharp tip. The legs both extend along a plane. The body defines a guide opening. The guide opening is oriented transversely relative to the plane associated with the legs. The guide opening is sized to receive a cannula having a generally flat profile. The guide opening is configured to guide the cannula through a sclerotomy at a substantially tangential orientation.
    Type: Application
    Filed: April 28, 2021
    Publication date: August 12, 2021
    Inventors: Brendan J. Oberkircher, Benjamin L. Ko, Robert H. Roth, Mark S. Ortiz, Thomas E. Meyer, Franklin S. Busch, Isaac J. Khan, Michael F. Keane, Anna R. Raymond, Jacob W. Schubert
  • Patent number: 11076984
    Abstract: A method includes inserting a flexible cannula between a sclera and a choroid of an eye. The needle is advanced from a distal end of the flexible cannula, such that the needle pierces the choroid to access a subretinal space of the eye. The needle is used to aspirate fluid from the subretinal space. The fluid may be present from a retinal detachment, a macular hemorrhage, or other condition present before the procedure begins. The method may further include injecting the fluid in the subretinal space via the needle, in which case the fluid may be a balanced salt solution or other bleb fluid. The method may further include injecting a therapeutic agent into the subretinal space after aspirating the bleb fluid. The volume of injected bleb fluid may be greater than the volume of injected therapeutic agent.
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: August 3, 2021
    Assignee: GYROSCOPE THERAPEUTICS LIMITED
    Inventors: Daniel W. Price, Brendan J. Oberkircher, Daniel J. Prenger, Geoffrey King, Isaac J. Khan, Michael F. Keane, Benjamin L. Ko
  • Patent number: 11058576
    Abstract: An apparatus for delivering therapeutic agent to an eye comprises a body, a cannula, a hollow needle, and an actuation assembly. The cannula extends distally from the body and is sized and configured to be insertable between a choroid and a sclera of a patient's eye. The actuation assembly is operable to actuate the needle relative to the cannula to thereby drive a distal portion of the needle along an exit axis that is obliquely oriented relative to the longitudinal axis of the cannula. The cannula may be inserted through a sclerotomy incision to position a distal end of the cannula at a posterior region of the eye, between the choroid and sclera. The needle may be advanced through the choroid to deliver the therapeutic agent adjacent to the potential space between the neurosensory retina and the retinal pigment epithelium layer, adjacent to the area of geographic atrophy.
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: July 13, 2021
    Assignee: GYROSCOPE THERAPEUTICS LIMITED
    Inventors: Brendan J. Oberkircher, Daniel W. Price, Michael F. Keane, Saeed Sokhanvar, Daniel J. Yasevac, Michel G. Bruehwiler, Leah R. Soffer, Isaac J. Khan, Benjamin L. Ko, Christopher D. Riemann, Nathan D. Grubbs
  • Patent number: 11000410
    Abstract: An apparatus includes a body and a pair of rigid legs extending from the body. The body includes an engagement feature configured to engage a deployment instrument. The legs are parallel with each other. Each leg has a sharp tip. The legs both extend along a plane. The body defines a guide opening. The guide opening is oriented transversely relative to the plane associated with the legs. The guide opening is sized to receive a cannula having a generally flat profile. The guide opening is configured to guide the cannula through a sclerotomy at a substantially tangential orientation.
    Type: Grant
    Filed: May 31, 2017
    Date of Patent: May 11, 2021
    Assignee: GYROSCOPE THERAPEUTICS LIMITED
    Inventors: Brendan J. Oberkircher, Benjamin L. Ko, Robert H. Roth, Mark S. Ortiz, Thomas E. Meyer, Franklin S. Busch, Isaac J. Khan, Michael F. Keane, Anna R. Raymond, Jacob W. Schubert
  • Publication number: 20210007890
    Abstract: An apparatus includes a body, a needle, a catheter, and an actuator assembly. The needle extends distally from the body. The needle has an inner wall defining a needle lumen. The needle lumen is in fluid communication with a fluid port of the body. The catheter is slidably disposed in the needle lumen. The catheter has a catheter lumen. The first actuator assembly is configured to translate the catheter within and relative to the needle. The apparatus may also include an actuator assembly that is configured to rotate the needle relative to the body. The apparatus may be used to first deliver a leading bleb of fluid to the subretinal space in a patient's eye via the needle. The apparatus may then be used to deliver a therapeutic agent to the subretinal space in the patient's eye via the catheter.
    Type: Application
    Filed: September 28, 2020
    Publication date: January 14, 2021
    Inventors: Michael F. Clem, Benjamin L. Ko, Robert H. Roth, Daniel J. Abbott, Thomas E. Meyer, Paul D. Gordon
  • Patent number: 10821021
    Abstract: An apparatus includes a body, a needle, a catheter, and an actuator assembly. The needle extends distally from the body. The needle has an inner wall defining a needle lumen. The needle lumen is in fluid communication with a fluid port of the body. The catheter is slidably disposed in the needle lumen. The catheter has a catheter lumen. The first actuator assembly is configured to translate the catheter within and relative to the needle. The apparatus may also include an actuator assembly that is configured to rotate the needle relative to the body. The apparatus may be used to first deliver a leading bleb of fluid to the subretinal space in a patient's eye via the needle. The apparatus may then be used to deliver a therapeutic agent to the subretinal space in the patient's eye via the catheter.
    Type: Grant
    Filed: February 15, 2018
    Date of Patent: November 3, 2020
    Assignee: GYROSCOPE THERAPEUTICS LIMITED
    Inventors: Michael F. Clem, Benjamin L. Ko, Robert H. Roth, Daniel J. Abbott, Thomas E. Meyer, Paul D. Gordon
  • Patent number: 10806629
    Abstract: An apparatus includes a pad assembly, an injector assembly, an injector driver, and a fluid source. The pad assembly is sized and configured to be placed on a forehead of a patient. The injector assembly includes a body, a flexible cannula, and a needle. The body is configured to be removably secured to the pad assembly. The cannula is sized to be inserted through an incision in an eye of a patient. The needle is slidably disposed in the cannula. The injector driver is operable to drive the needle longitudinally relative to the flexible cannula. The fluid source assembly is in fluid communication with the needle.
    Type: Grant
    Filed: May 31, 2017
    Date of Patent: October 20, 2020
    Assignee: GYROSCOPE THERAPEUTICS LIMITED
    Inventors: Daniel W. Price, Brendan J. Oberkircher, James G. Lee, Clinton Denlinger, Daniel J. Prenger, Geoffrey King, Scott Uhland, Mark C. Tsai, Michael F. Keane, Isaac J. Khan, Benjamin L. Ko, Thomas E. Meyer, Denis P. Turner
  • Patent number: 10806630
    Abstract: An apparatus includes a pad assembly, an injector assembly, an injector driver, and a fluid source. The pad assembly is sized and configured to be placed on a forehead of a patient. The injector assembly includes a body, a flexible cannula, and a needle. The body is configured to be removably secured to the pad assembly. The cannula is sized to be inserted through an incision in an eye of a patient. The needle is slidably disposed in the cannula. The injector driver is operable to drive the needle longitudinally relative to the flexible cannula. The fluid source assembly is in fluid communication with the needle.
    Type: Grant
    Filed: April 29, 2020
    Date of Patent: October 20, 2020
    Assignee: GYROSCOPE THERAPEUTICS LIMITED
    Inventors: Daniel W. Price, Brendan J. Oberkircher, James G. Lee, Clinton Denlinger, Daniel J. Prenger, Geoffrey King, Scott Uhland, Mark C. Tsai, Michael F. Keane, Isaac J. Khan, Benjamin L. Ko, Thomas E. Meyer, Denis P. Turner
  • Publication number: 20200297531
    Abstract: An apparatus includes a pad assembly, an injector assembly, an injector driver, and a fluid source. The pad assembly is sized and configured to be placed on a forehead of a patient. The injector assembly includes a body, a flexible cannula, and a needle. The body is configured to be removably secured to the pad assembly. The cannula is sized to be inserted through an incision in an eye of a patient. The needle is slidably disposed in the cannula. The injector driver is operable to drive the needle longitudinally relative to the flexible cannula. The fluid source assembly is in fluid communication with the needle.
    Type: Application
    Filed: April 29, 2020
    Publication date: September 24, 2020
    Inventors: Daniel W. Price, Brendan J. Oberkircher, James G. Lee, Clinton Denlinger, Daniel J. Prenger, Geoffrey King, Scott Uhland, Mark C. Tsai, Michael F. Keane, Isaac J. Khan, Benjamin L. Ko, Thomas E. Meyer, Denis P. Turner
  • Patent number: 10646374
    Abstract: An apparatus includes an injector, a first fluid conduit, a second fluid line, and a control module. The injector includes a body, a flexible cannula, a flexible needle, and a sensor. The needle is configured to translate relative to the cannula. The sensor is operable to detect a position of the needle relative to the cannula. The first and second fluid lines are coupled with the needle. The control module is in communication with the sensor, with the first fluid conduit, and with the second fluid conduit. The control module is configured to provide delivery of a first fluid through the first conduit to the needle based on a signal from the sensor. The control module is further configured to provide delivery of a second fluid through the second conduit to the needle.
    Type: Grant
    Filed: May 31, 2017
    Date of Patent: May 12, 2020
    Assignee: ORBIT BIOMEDICAL LIMITED
    Inventors: Daniel W. Price, Brendan J. Oberkircher, Daniel J. Prenger, Geoffrey King, Thomas E. Meyer, Benjamin L. Ko
  • Publication number: 20200078514
    Abstract: An apparatus includes a body, a cannula, and a needle. The cannula is flexible and extends distally from the body. The needle is slidably disposed in the cannula. The needle includes a sharp distal tip and a curved portion. The needle is configured to translate relative to the cannula between a proximal position and a distal position. The distal tip is configured to be positioned inside the cannula when the needle is in the proximal position. The distal tip is configured to be positioned outside the cannula when the needle is in the distal position. The needle is resiliently biased to extend along a curve through the curved portion.
    Type: Application
    Filed: October 11, 2019
    Publication date: March 12, 2020
    Inventors: Thomas E. Meyer, Benjamin L. Ko, Isaac J. Khan, Daniel W. Price, Brendan J. Oberkircher, Michael F. Keane
  • Patent number: 10478553
    Abstract: An apparatus includes a body, a cannula, and a needle. The cannula is flexible and extends distally from the body. The needle is slidably disposed in the cannula. The needle includes a sharp distal tip and a curved portion. The needle is configured to translate relative to the cannula between a proximal position and a distal position. The distal tip is configured to be positioned inside the cannula when the needle is in the proximal position. The distal tip is configured to be positioned outside the cannula when the needle is in the distal position. The needle is resiliently biased to extend along a curve through the curved portion.
    Type: Grant
    Filed: February 22, 2017
    Date of Patent: November 19, 2019
    Assignee: ORBIT BIOMEDICAL LIMITED
    Inventors: Thomas E. Meyer, Benjamin L. Ko, Isaac J. Khan, Daniel W. Price, Brendan J. Oberkircher, Michael F. Keane
  • Publication number: 20190142634
    Abstract: An apparatus for delivering therapeutic agent to an eye comprises a body, a cannula, a hollow needle, and an actuation assembly. The cannula extends distally from the body and is sized and configured to be insertable between a choroid and a sclera of a patient's eye. The actuation assembly is operable to actuate the needle relative to the cannula to thereby drive a distal portion of the needle along an exit axis that is obliquely oriented relative to the longitudinal axis of the cannula. The cannula may be inserted through a sclerotomy incision to position a distal end of the cannula at a posterior region of the eye, between the choroid and sclera. The needle may be advanced through the choroid to deliver the therapeutic agent adjacent to the potential space between the neurosensory retina and the retinal pigment epithelium layer, adjacent to the area of geographic atrophy.
    Type: Application
    Filed: November 8, 2018
    Publication date: May 16, 2019
    Inventors: Brendan J. Oberkircher, Daniel W. Price, Michael F. Keane, Saeed Sokhanvar, Daniel J. Yasevac, Michel G. Bruehwiler, Leah R. Soffer, Isaac J. Khan, Benjamin L. Ko, Christopher D. Riemann, Nathan D. Grubbs